CDKN2A and neurofibroma: Finally, a splice site substitution mutation trimming CDKN2A exon 2 and severely affecting both p16INK4A and p14ARF was described in a family with melanomas, neurofibromas and multiple dysplastic nevi (Petronzelli et al, 2001).